Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAib Group Regulatory News (AIBG)

Share Price Information for Aib Group (AIBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 433.00
Bid: 428.00
Ask: 430.00
Change: 3.00 (0.70%)
Spread: 2.00 (0.467%)
Open: 422.00
High: 433.00
Low: 422.00
Prev. Close: 430.00
AIBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIB Group plc – EBA European-Wide Stress Test 2021

30 Jul 2021 17:28

RNS Number : 1339H
AIB Group PLC
30 July 2021
 

 

 

30 July 2021

 

AIB Group plc - European Banking Authority (EBA) European-Wide Stress Test 2021

 

CFO Comment on EBA EU Wide Stress Test

 

"Our result of 8.8% fully loaded CET1 in the adverse scenario demonstrates our high capital base and capital resilience in the face of a very severe EBA adverse scenario. AIB continues to be very well-capitalised with a CET1 ratio of 15.8% at Q1 2021 and we will update further when we announce H1 Results on the 4th August."

-Donal Galvin, CFO

Results of EBA EU Wide Stress Test

 

AIB Group plc ("AIB") was subject to the 2021 EUwide stress test conducted by the European Banking Authority (EBA), in cooperation with the Central Bank of Ireland (CBI), the European Central Bank (ECB), the European Commission (EC) and the European Systemic Risk Board (ESRB).

 

AIB notes the announcements made today by the EBA on the EU-wide stress test and fully acknowledge the outcomes of this exercise.

 

AIB's capital ratios and EBA stress test results are outlined below:

 

AIB CET 1 Capital Ratios

Dec 2020

CET 1 - Transitional

18.9%

CET 1 - Fully loaded

15.6%

 

 

EBA Stress Test Results

Stress Test 2021

CET 1 - Transitional adverse scenario

9.6%

CET 1 - Fully loaded adverse scenario

8.8%

 

The 2021 EU-wide stress test does not contain a pass fail threshold and instead is designed to be used as an important source of information for the purposes of the Supervisory Review and Evaluation Process (SREP). The results will assist competent authorities in assessing AIB's ability to meet applicable prudential requirements under stressed scenarios.

 

The adverse stress test scenario was set by the ECB/ESRB and covers a three-year time horizon (2021-2023). The stress test has been carried out applying a static balance sheet assumption as of December 2020, and therefore does not take into account future business strategies and management actions. It is not a forecast of AIB's profits.

 

No capital action is required for AIB as a result of the EBA Stress Test Results.

 

AIB notes the following:

· AIB is well capitalised with a CET1 fully loaded ratio at Q1 2021 of 15.8%, well ahead of our opening minimum regulatory requirement (SREP) of 10.19%

· AIB has filled its AT1 and Tier 2 buckets under Art 104 a. which reduces AIB's Pillar 2 CET1 requirement from 3.00% to 1.69%

· AIB's very strong capital starting level (December 2020: CET1 15.6%) which included the impact of €1.4bn ECL charge in 2020 gives us significant comfort about the overall result (EBA Stress Test Adverse Scenario: depletion of 6.8% to give CET1 of 8.8%) which was well above the total SREP capital requirements (TSCR) of 6.19%

 

To view the results including disclosure templates published by EBA for AIB please click herehttp://www.rns-pdf.londonstockexchange.com/rns/1339H_1-2021-7-30.pdf

 

AIB Group plc will publish its half-yearly 2021 financial results on 4 August 2021 at 07:00 IST

 

-ENDS-

[1] FY 2021 SREP is 10.19%; SREP requirement does not include Pillar 2 Guidance (P2G).

For further information, please contact:

Niamh Hore / Janet McConkey

Paddy McDonnell

Investor Relations

Media Relations

AIB Group

AIB Group

Dublin

Dublin

Tel: +353-1-6411817 / +353-1-6418974

Tel: +353-87-7390743

email: niamh.a.hore@aib.ie

janet.e.mcconkey@aib.ie

email: paddy.x.mcdonnell@aib.ie

 

 

Forward Looking Statements

 

This document contains certain forward looking statements with respect to the financial condition, results of operations and business of AIB Group and certain of the plans and objectives of the Group. These forward looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward looking statements sometimes use words such as 'aim', 'anticipate', 'target', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'may', 'could', 'will', 'seek', 'continue', 'should', 'assume', or other words of similar meaning. Examples of forward looking statements include, among others, statements regarding the Group's future financial position, capital structure, Government shareholding in the Group, income growth, loan losses, business strategy, projected costs, capital ratios, estimates of capital expenditures, and plans and objectives for future operations. Because such statements are inherently subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward looking information. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward looking statements. These are set out in the Principal risks on pages 50 to 53 in the 2020 Annual Financial Report. In addition to matters relating to the Group's business, future performance will be impacted by direct and indirect impacts of the COVID-19 pandemic and by Irish, UK and wider European and global economic and financial market considerations. Any forward looking statements made by or on behalf of the Group speak only as of the date they are made. The Group cautions that the list of important factors on pages 50 to 53 of the 2020 Annual Financial Report is not exhaustive. Investors and others should carefully consider the foregoing factors and other uncertainties and events when making an investment decision based on any forward looking statement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSDAFISEFSELW
Date   Source Headline
9th May 20245:11 pmRNSHolding(s) in Company
9th May 20244:53 pmRNSHolding(s) in Company
8th May 202410:33 amRNSTotal Voting Rights
7th May 20245:36 pmRNSHolding(s) in Company
7th May 20247:00 amRNSHolding(s) in Company
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20246:01 pmRNSResult of Meeting
2nd May 20246:00 pmRNSResult of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Statement
26th Apr 202410:13 amRNSRE EGM: Final Price in respect of Buyback Contract
24th Apr 20249:32 amRNSStabilisation Notice
23rd Apr 20245:16 pmRNSHolding(s) in Company
23rd Apr 20249:23 amRNSStabilisation Notice
3rd Apr 20243:00 pmRNSNotice of GM
3rd Apr 20243:00 pmRNSNotice of AGM
25th Mar 20248:34 amRNSHolding(s) in Company
11th Mar 20249:51 amRNSDirector/PDMR Shareholding
6th Mar 20247:15 amRNSDividend Declaration
6th Mar 20247:00 amRNS2023 Annual Financial Results Announcement
4th Mar 20244:25 pmRNSHolding(s) in Company
27th Feb 20242:23 pmRNSHolding(s) in Company
16th Feb 20243:35 pmRNSHolding(s) in Company
30th Jan 202412:36 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSFurther Renewal of the AIB share trading plan
14th Dec 20233:37 pmRNSHolding(s) in Company
11th Dec 20233:40 pmRNSHolding(s) in Company
24th Nov 20235:31 pmRNSHolding(s) in Company
8th Nov 20235:17 pmRNSHolding(s) in Company
8th Nov 202311:43 amRNSHolding(s) in Company
7th Nov 20235:35 pmRNSHolding(s) in Company
7th Nov 20237:08 amRNSAIB Group plc - Statement on State Divestment
7th Nov 20237:00 amRNSDisposal of approximately 5% of AIB Group plc
6th Nov 202311:34 amRNSHolding(s) in Company
1st Nov 20237:00 amRNSQ3 2023 Trading Statement
18th Oct 20239:58 amRNSStabilisation Notice
18th Oct 20239:00 amRNSHolding(s) in Company
16th Oct 20239:32 amRNSStabilisation Notice
11th Oct 20234:19 pmRNSHolding(s) in Company
21st Sep 20234:29 pmRNSHolding(s) in Company
1st Sep 20231:31 pmRNSHolding(s) in Company
21st Aug 20234:07 pmRNSHolding(s) in Company
28th Jul 20235:51 pmRNSEBA European-wide stress test 2023
28th Jul 20237:00 amRNSHalf-year Report 2023
13th Jul 20235:53 pmRNSHolding(s) in Company
11th Jul 202312:45 pmRNSHolding(s) in Company
30th Jun 20235:59 pmRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
30th Jun 20237:00 amRNSHolding(s) in Company
28th Jun 20237:05 amRNSAIB Group plc - Statement on State Divestment
28th Jun 20237:00 amRNSResults of Secondary Placing in AIB Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.